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1 Abbreviations 
 
aa  amino acid 
ACSL  long-chain acyl-CoA synthetase 
ADRP  adipose differentiation-related protein  
AGPAT 1-acylglycerol-3-phosphate O-acyltransferase 
ALG  asparagine linked glycosylation 
ApoE  apolipoprotein E  
ATGL  adipose triglyceride lipase 
cAMP  cyclic adenosine monophosphate 
CCT  CTP:phosphocholine cytidylyltransferase 
CIDEC cell death-inducing DFF45-like effector C 
CK  choline kinase 
CoA  Coenzyme A 
COPI  coat protein complex I 
CPT  CDP-choline:1,2-diacylglycerol cholinephosphotransferase 
CTP  cytidine triphosphate 
DG  diacylglycerol 
DGAT  acyl-CoA:diacylglycerol O-acyltransferase 
eLD  expanding LD 
EM  electron microscopy 
ePC  ether-linked phosphatidylcholine  
ePE  ether-linked phosphatidylehtanolamine  
ER  endoplasmic reticulum 
FSP27 fat-specific protein of 27 kDa 
GPAT  glycerol-3-phosphate O-acyltransferase  
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GUV  giant unilamellar vesicles 
HCV  Hepatitis C virus 
HSL  hormone-sensitive lipase 
LD  lipid droplet 
LPLAT lyso-phospholipid acyltransferases 
MG  monoacylglycerol 
MGL  monoacylglycerol lipase 
MTP  microsomal triacylglycerol transfer protein 
PA  phosphatidic acid 
PAP  phosphatidic acid phosphatase 
PC  phosphatidylcholine  
PCP  protein correlation profiling 
PCTP  phosphatidylcholine transfer protein  
PE  phosphatidylethanolamine  
PEMT  phosphatidylethanolamine N-methyltransferase 
PI  phosphatidylinositol  
PKA  protein kinase A 
PLA2  phospholipase A2 
PS  phosphatidylserine  
Rab18 Ras-related in brain 18 
RNAi  RNA-interference 
SE   sterol ester 
sLD  static LD 
SNARE  soluble N-ethylmaleimide-sensitive factor attachment receptor proteins 
TG  triacylglycerol 
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3 Summary 
Most cells and organisms store metabolic energy in times of excess supply in the 
form of triacylglycerol (TG), packaged into cytosolic lipid droplets (LDs). LDs are 
dynamic organelles consisting of a neutral lipid core bounded by a monolayer of 
phospholipids into which specific proteins are incorporated (Walther and Farese, 
2012). The current model for LD formation posits that they emerge from the ER. 
There, a TG lens forms between the ER membrane leaflets, eventually budding as a 
droplet into the cytosol (Walther and Farese, 2012). How proteins and newly 
synthesized neutral lipids are delivered to nascent LDs is unclear. 
In the present thesis I investigated the mechanism of protein targeting from the ER to 
LDs and the importance of the targeted proteins for LD growth. Most of the enzymes 
of the TG synthesis pathway (e.g. ACSLs, GPATs, AGPATs, DGATs) are thought to 
be localized in the endoplasmic reticulum and contain several predicted 
transmembrane domains (Coleman and Lee, 2004). Fluorescence microscopy 
combined with high confidence proteomics identified that specific isoenzymes 
catalyzing each step of de novo TG synthesis localize to forming LDs. As a marker 
protein for this relocalization process I focused on GPAT4, which is the rate-limiting 
enzyme in the TG synthesis pathway (Coleman and Mashek, 2011). I showed that 
GPAT4 re-localizes from the ER along ER-LD membrane bridges to the surface of a 
subset of nascent LDs upon culture with oleate. At the LD surface, these enzymes 
mediate LD growth of a subpopulation by local TG synthesis. A second LD 
subpopulation, not targeted by these enzymes, does not expand after formation. 
Knockdown of the COPI machinery leads to the lack of expanding LDs and results in 
smaller, uniformly sized LDs, while depletion of the COPI machinery further impairs 
targeting of some proteins, including ATGL, to LDs. I show that GPAT4 targeting to 
LDs is dependent on the COPI machinery. My current model suggests that the COPI 
machinery modulates the LD surface, allowing the formation of connections between 
the ER and LDs for targeting of key TG metabolism enzymes, such as GPAT4. Our 
data suggest that, in addition to the classical role in vesicular trafficking, the COPI 
machinery also removes surfactant phospholipids from the LD-delimiting monolayer 
by budding 60 nm nano-LDs from the surface of LDs. Modulation of the LD surface, 
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in turn, is required and sufficient to allow targeting of GPAT4 even in the absence of 
a functional COPI machinery.  
My findings highlight a general mechanism of how specific proteins re-localize from 
the ER to LDs, explaining how TG synthesis is coupled with LD growth and identify 
LD subpopulations based on their capacity for LD localized TG synthesis. The key 
features of GPAT4 ER-to-LD targeting and function in LD growth are conserved 
between Drosophila and mammalian cells. My results further reveal a new 
mechanism of protein targeting to LDs, which operates by modification of the target 
LD surfaces to establish connections that allow proteins to access cytosolic LDs. 
 
Aims 
 
   13 
4 Aims 
The global prevalence in obesity is linked to an increased prevalence of insulin 
resistance and pandemic type 2 diabetes. In the U.S., more than one-third of the 
adults (35.7%) are obese (Ogden et al., 2012). At the heart of these diseases lies 
excessive storage of neutral lipids, such as TG. TGs are stored in cytosolic LDs. LDs 
consists of a neutral lipid core surrounded by a phospholipid monolayer harboring a 
set of specific proteins (Walther and Farese, 2012). TG is synthesized by enzymes of 
the glycerolphosphate pathway (Yen et al., 2008). Many of these enzymes are found 
in the ER, mitochondria or in mitochondria-associated membranes and occur in 
multiple isoforms (Coleman and Lee, 2004). Most of the TG synthesis enzymes are 
predicted multitopic trans-membrane proteins present in the ER. However, a subset 
of TG synthesis enzymes is strongly enriched in the purified LD fraction analyzed by 
proteomics. Other proteins, such as Dga1 or METTL7B, first localize to the ER and 
then concentrate on LDs during their formation (Jacquier et al., 2011; Zehmer et al., 
2009; Zehmer et al., 2008). How re-localization of ER proteins to LDs is 
mechanistically achieved is unknown. Whether and how newly synthesized TG is 
delivered to nascent LDs after the initial formation is unclear. The current model for 
LD formation posits that LDs emerge from the ER as a TG lens between the ER 
membrane leaflets that bud as a LD into the cytosol (Walther and Farese, 2012).  
I propose that cytosolic LDs grow by local TG synthesis at the LD surface. I will 
determine the spatial organization of TG synthesis enzymes and their function for LD 
formation and growth by completing the following specific aims: 
Aim 1: Determine the spatial organization of TG synthesis enzymes in 
Drosophila S2 cells. Our proteome data from Drosophila melanogaster S2 cells 
suggest that a subset of TG synthesis enzymes localizes to LDs. I will test this 
hypothesis by determining the localization of fluorescently tagged TG synthesis 
enzymes in respect to known marker proteins. 
Aim 2: Determine the mechanism of TG synthesis enzyme re-localization from 
the ER to LDs. Some ER proteins are able to re-localize from the ER to LDs by (a) 
yet unknown mechanism(s). Our preliminary data suggest that enzymes of the TG 
Aims 
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synthesis pathway, such as GPAT4, follow this pathway. I will determine the topology 
of GPAT4, the rate-limiting enzyme in the TG synthesis pathway.  
Aim 3: Determine the function of the TG synthesis enzyme re-localization in 
relationship to the growth of LDs. LDs most likely form at the ER. In many cell 
types, their size and number varies strongly, suggesting that LDs grow after their 
initial formation. How size and number of LDs are regulated and coordinated is 
unknown. I will test the hypothesis that LDs grow by locally generating TG, catalyzed 
by enzymes located on the LD surface.  
The proposed work addresses a fundamental question. How is metabolic energy 
stored in TG during times of excess supply? In particular, I will reveal the mechanism 
of LD expansion and additionally give insights into trafficking of proteins from the ER 
to LDs. 
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5 Introduction 
 
Almost all cells and organisms store metabolic energy in times of excess supply. The 
most compact storage form of metabolic energy is triacylglycerol (TG) that is 
packaged in cytosolic organelles called lipid droplets (LDs). These spherical 
organelles are present in almost all organisms and contain, depending on the cell 
type, other neutral lipids such as sterol esters (SEs). For a long time LDs were 
considered inert cytoplasmic inclusions of neutral lipids. In the last decade it has 
been shown that LDs are not inert structures but that the formation and turnover of 
these organelles are highly regulated according to cellular needs for energy. Besides 
storing lipids, LDs are linked to many cellular functions including energy generation, 
membrane synthesis, viral replication, and protein degradation. Excessive storage of 
neutral lipids in LDs is a key step to pathogenesis of many metabolic diseases, such 
as obesity, diabetes and atherosclerosis.  
The number and size of LDs can vary greatly. How LDs form and grow is still poorly 
understood. To understand how LDs grow after their initial formation, I investigated 
the spatial organization of TG synthesis enzymes and their contribution to LD 
expansion. 
 
5.1 Structure and composition of LDs 
LDs are the main storage organelle for neutral lipids in the cell. They can be found in 
most prokaryotes and eukaryotes. They consist of a neutral lipid core surrounded by 
a phospholipid monolayer harboring a set of specific proteins (Figure 1). The number 
and size of LDs can vary greatly, from 50 nm diameter found in milk-secreting cells to 
200 µm diameter found in mature adipocytes (Murphy, 2001). Depending on the 
energy intake number and size of LDs can change rapidly by several orders of 
magnitude (Guo et al., 2009).  
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Figure 1: Architecture of a cytosolic lipid droplet. Schematic overview of the structure and 
composition of a cytosolic lipid droplet. 
 
5.1.1 Phospholipid composition 
Although LDs originate from the endoplasmic reticulum (ER) they have a distinct 
phospholipid composition that is different from that of the ER and other organelles 
(Tauchi-Sato et al., 2002). The composition of the phospholipid monolayer is 
dependent on the cell type and includes many diverse phospholipid species. The 
main phospholipids are phosphatidylcholine (PC), phosphatidylethanolamine (PE), 
phosphatidylinositol (PI), ether-linked phosphatidylcholine (ePC), and ether-linked 
phosphatidylehtanolamine (ePE). The monolayer of LDs is further enriched in 
lysoPE, lysoPC, free-cholesterol and PC but deficient in sphingomyelin, 
phosphatidylserine (PS), and phosphatidic acid (PA) when compared to total 
membranes (Bartz et al., 2007a; Tauchi-Sato et al., 2002). In CHO cells more than 
160 phospholipids species with varying head groups and side chains were detected 
(Bartz et al., 2007a).  
The hydrophobic core of LDs consists of neutral lipids, most of them TGs and SEs. 
Their relative amount varies significantly among cell types. In different cells types, 
depending on the cell function, various other neutral lipids are found in the core of 
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LDs. For example retinyl esters are found in LDs of hepatic stellate cells as well as in 
LDs isolated from bovine retinal pigmented epithelium (Orban et al., 2011; Walther 
and Farese, 2012). In some mammalian cells LDs can also contain wax esters and 
ether lipids, which are derived from peroxisomes (Bartz et al., 2007a). The production 
of these lipids allows storage and detoxification of many neutral lipids.  
 
5.1.2 Protein composition 
The LD is the only compartment in the cell with a phospholipid monolayer instead of 
a bilayer. This unique structure of LDs and their specific phospholipid composition 
allow targeting of a specific set of proteins. The first protein identified to be specific 
for LDs was perilipin1 (Greenberg AS 1991). Today five members of the perilipin 
family are known (perilipin1-5). Analyses of LD proteomes in different organisms 
resulted in various lists of LD-associated proteins (Athenstaedt et al., 1999; Beilstein 
et al., 2013; Beller et al., 2006; Brasaemle et al., 2004; Cermelli et al., 2006; Ding et 
al., 2012a; Ding et al., 2012b; Fujimoto et al., 2004; Ivashov et al., 2013; Liu et al., 
2004; Orban et al., 2011; Sato et al., 2006; Wan et al., 2007; Zhang et al., 2011; 
Zhang et al., 2012). The overlap of the published proteomes is very low illustrating 
the difficulty of purifying these organelles to homogeneity since LDs are often found 
in very close proximity to other organelles (Figure 2). In the case of the ER, the 
distance between the two compartments can be less than 40 nm (Robenek et al., 
2006). A major group of proteins identified by proteomics studies are enzymes of lipid 
metabolism such as acyl-CoA synthetases, lipases that act on triglyceride, and 
enzymes of sterol biogenesis. Furthermore, many well-characterized proteins have 
been found on LDs that previously had been assigned a different subcellular 
localization. It is possible that some of these proteins have a dual localization, such 
as histones (Cermelli et al., 2006), but likely most of these proteins are contaminants 
due to the high sensitivity of the mass spectrometer. The lack of a protocol for 
purifying LDs to homogeneity further complicates the identification of LD proteins. 
Ideally, a combination of different methods is used to confirm the lipid droplet 
localization of a protein. 
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Figure 2: Lipid droplets are in close contact to other organelles. Shown is an electron micrograph 
of a single lipid droplet from a rat hepatoma cell (image courtesy of S. Stone and J. Wong). 
Abbreviation: ER, endoplasmic reticulum; LD, lipid droplet; M, mitochondria; N, nucleus 
 
5.2 Protein targeting to LDs 
It is poorly understood how proteins are targeted to LDs. Proteins identified in the LD 
proteome can be divided into at least three different structural classes: peripherally 
associated proteins such as the perilipin family members, lipid-anchored proteins of 
the small GTPase type, and monotopic integral membrane proteins. Polytopic 
membrane proteins have been reported in LD proteome lists, but so far no 
localization to LDs was confirmed for this group of proteins, suggesting that they 
represent contamination of the LD fraction with other membranes. Several 
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mechanism are emerging that mediate direct targeting to the LD surface (Walther 
and Farese, 2012). An overview of these features is shown in Figure 3. 
 
Figure 3: Schematic overview of different binding motives for lipid droplet proteins. (adapted 
from Walther and Farese, 2012). 
 
5.2.1 Amphipathic α-helix 
One structural feature that allows proteins to directly bind to the LD surface is the 
membrane-binding amphipathic α-helix. The amphipathicity results from the 
segregation of hydrophobic and polar residues between the two opposite faces of the 
α-helix (Drin and Antonny, 2010). Several different proteins harboring this motif have 
been described to target to the LD surface. Among these proteins perilipin3/TIP47 is 
the best-characterized protein. The crystal structure of the C-terminal portion of 
perilipin3 reveals four amphipathic helices that form a hydrophilic bundle similar to 
the one found in apolipoprotein E (ApoE) (Hickenbottom et al., 2004). During lipid 
binding the amphipathic helix bundle of ApoE opens to expose the hydrophobic faces 
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of the amphipathic helices. These interact with the surface phospholipid monolayer of 
lipoproteins (Hatters et al., 2006; Lu et al., 2000). Based on the high structural 
homology to ApoE, similar properties may allow perilipin3 to bind to the LD surface. It 
is yet unknown how the binding specificity of amphipathic-helices to the LD surface 
compared to other membranes is accomplished. For perilipin3 it is suggested that it 
binds diacylglycerol (DG) rich membranes in the ER during the formation of LDs 
(Skinner et al., 2009). Other examples for proteins targeted to the LD surface via 
amphiphatic-helices are the Hepatitis C virus (HCV) core protein, viperin 
(endogenous inhibitor of HCV), and CTP:phosphocholine cytidylyltransferase  (CCT) 
(Barba et al., 1997; Hinson and Cresswell, 2009). 
 
5.2.2 Short hydrophobic regions localized at the N-terminus 
Similar to signal sequence-containing or tail anchor proteins, which possess a 
transmembrane domain at the N- or C-terminus, proteins have been identified that 
bind to LDs via a N-terminal short hydrophobic domain. This domain is necessary 
and sufficient for the targeting of proteins to the LD surface. The most studied 
proteins of this group are AAM-B and ALDI (Turro et al., 2006; Zehmer et al., 2009; 
Zehmer et al., 2008). It is notable that these proteins localize to the ER in the 
absence of LDs. In cells where protein synthesis is blocked the existing protein pool 
can still target to LDs (Zehmer et al., 2009). How the targeting of these proteins from 
the ER to LDs is achieved is not clear. 
 
5.2.3 Internal hydrophobic domains that are embedded in the LD 
A subset of proteins binds to the monolayer surface of LDs with an internal 
hydrophobic domain, which likely forms hairpin structures. This topology allows a 
membrane-embedding of the protein in such a way that the N- and C-terminus of the 
protein are facing the cytosol with the hydrophobic domain of the hairpin inside the 
core of the LD. Proteins harboring a hairpin domain could be targeted to a monolayer 
or bilayer. Examples for such proteins are the plant oleosins. Arabidopsis oleosins 
are integrated into membranes by a cotranslational, translocon-mediated pathway in 
vitro. The long hydrophobic hairpin domain prevents the C-terminal domain from 
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translocating into the ER lumen (Abell et al., 2002). This feature of the hairpin domain 
leads to a topology where the protein is embedded into the membrane by the hairpin 
with the N- and the C-terminus facing the cytosol. After translocation into the ER 
oleosins are targeted to LDs. Within the hydrophobic hairpin the “proline knot” motif is 
important for targeting of oleosins to LDs. The proline knot motif of oleosins is a short 
sequence of 12 amino acids (aa), which contains 3 prolines. These prolines likely 
induce a kink in the two hydrophobic helix segments leading to the hairpin topology. 
Examples for proteins targeted to LDs by a hairpin motif in mammalian cells are 
caveolins and 17-hydroxysteroid dehydrogenases. Caveolins are found in many 
mammalian cells and contain a similar hairpin motif (Fujimoto et al., 2001; 
Ostermeyer et al., 2001; Pol et al., 2001). Caveolins are mainly found at the plasma 
membrane but a fraction of them has been identified to localize to LDs under 
physiological conditions (Fujimoto et al., 2001; Ostermeyer et al., 2001; Pol et al., 
2001). 
 
5.2.4 Interaction with lipid droplet-bound proteins 
Another possibility for proteins to localize to LDs is by interacting with LD-bound 
proteins. An example is the recruitment of hormone-sensitive lipase (HSL) to LDs. 
Under non-lipolytic conditions HSL is mostly cytosolic. Upon hormonal stimulation 
perilipin1 as well as HSL are getting phosphorylated. This leads to the interaction 
between HSL and perilipin1 and to the recruitment of HSL to LDs (Granneman et al., 
2007; Sztalryd et al., 2003). 
 
5.2.5 Lipid anchors 
Instead of binding to LD-bound proteins, proteins lacking hydrophobic protein 
segments can bind to cellular membranes through a lipid-anchor. The lipid anchor is 
a posttranslational modification by which at least one lipid moiety or fatty acid is 
attached to the protein. Naturally occurring lipid anchors are isoprenyl groups, e.g. 
farnesyl or geranylgeranyl, and saturated fatty acyl groups e.g. palmitoyl or myristoyl 
(Magee and Seabra, 2005). The by far most studied class of lipid-anchored proteins 
is the Ras family of small GTPases. Depending on the lipid anchor these proteins are 
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sorted and targeted to different membranes with different signaling effects (Mor and 
Philips, 2006). The small GTPase, Rab18 (Ras-related in brain 18), localizes to LDs 
by a C-terminal prenyl anchor combined with protein-protein interactions (Martin et 
al., 2005). This induces close apposition of LDs to ER. Interestingly, Rab18 contains 
a mono-cysteine prenylation motif rather than the di-cysteine prenylation motif that is 
present in most other Rab family members (Martin et al., 2005; Ozeki et al., 2005). 
 
5.3 Cellular pathways involved in targeting proteins from other 
organelles to lipid droplets 
Most LD proteins are cytosolic proteins, which are targeted by the described domains 
to LDs from the cytosol. How this is mechanistically achieved is mainly unknown. A 
large number of LD-associated proteins identified in the proteomes have been 
suggested to be membrane-bound proteins of the ER. Recently, a mechanism has 
been suggested according to which proteins harboring the described hairpin motifs or 
N-terminal hydrophobic domains are able to diffuse to LDs by ER-LD connection 
sites. As shown for Rab18, certain proteins can mediate the interaction of LDs with 
other organelles. Contact sites between LDs and other organelles could allow 
transfer of membrane bound proteins from one organelle to another (Figure 4). 
Cytosolic LDs could be either transiently or permanently associated with the ER. 
Given the mentioned topology features, certain membrane-bound proteins could 
diffuse along these connections to the surface of LDs. A number of proteins have 
been identified that are localizing to the ER in the absence of LDs, but when LDs are 
formed these proteins change their localization to the monolayer of LDs. Examples 
are the yeast proteins Dga1 and Erg6 as well as the mammalian proteins AAM-B and 
UBXD8. The movement of the yeast protein Dga1 from the ER membrane to LDs is 
independent of temperature and energy, suggesting that the relocalization is not 
mediated by classical vesicular transport routes (Jacquier et al., 2011). Connections 
of the ER and LDs have been visualized by electron microscopy in Neurospora 
crassa, maturing cotyledons of Pisum and Vicia faba (Wanner et al., 1981). Proteins 
might also target to LD-associated membranes. In freeze-fracture electron 
microscopy studies on lipid-laden macrophages LDs appeared to be wrapped by ER 
membranes in an “egg-cup” like fashion (Robenek et al., 2006). Given the resolution 
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limit of light microscopy, targeting to ER subdomains close to LDs could be falsely 
interpreted as targeting to the surface of LDs. Other interactions of LDs with 
endosomes, mitochondria, and peroxisomes have been suggested (Murphy et al., 
2009). These interactions with other organelles could explain the broad spectrum of 
proteins identified in many different proteomic studies. 
 
Figure 4: Possible mechanism of proteins targeting LDs. a) Proteins with a hydrophobic hairpin 
domain like the triacylglycerol synthesis enzyme DGAT2 might diffuse along membrane bridges onto 
LD. Proteins might target from the cytosol directly to LDs either by binding to the LD surface or by 
interaction with LD proteins. Some proteins might target to LD-associated membranes and this might 
be achieved by vesicular trafficking by the COPI machinery (adapted from Walther and Farese, 2012). 
b) The Electron micrograph shows connectivity between the ER and a lipid droplet (adapted from 
Wanner et al., 1981). LB, lipid body; ER, endoplasmic reticulum. 
 
Unbiased genome-wide screens in model systems, such as Drosophila cells, have 
started to reveal factors that are required for LD targeting of proteins (Beller et al., 
2008; Guo et al., 2008). Specifically, members of the coat protein complex I (COPI) 
machinery, but not other proteins involved in secretory trafficking (e.g., COPII or 
clathrin), are required for normal LD morphology and function (Beller et al., 2008; 
Guo et al., 2008). The COPI machinery is a protein complex important for retrograde 
trafficking of proteins from the golgi back to the ER (Nickel et al., 2002). The 
depletion of Arf1/COPI proteins from cells leads to the formation of uniformly sized, 
lipolysis-resistant LDs that lack the major TG lipase adipose triglyceride lipase 
(ATGL) (Beller et al., 2008; Guo et al., 2008; Soni et al., 2009). Besides ATGL other 
proteins have been identified to be dependent on the COPI machinery for targeting to 
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LDs. Examples are phospholipase D and adipose differentiation-related protein 
(ADRP) (Nakamura et al., 2005; Soni et al., 2009). In one model the COPI machinery 
transports certain LD proteins by vesicular transport to LD-associated membranes 
(Figure 4). Interestingly, depleting the COPII machinery that is important for 
anterograde trafficking from the ER to the golgi has only a mild effect on the targeting 
of COPI dependent proteins, such as ATGL, to LDs (Soni et al., 2009). This mild 
effect on targeting of proteins to LDs suggests that classical trafficking might not be 
the mechanism that targets specific proteins to LDs or LD-associated membranes. It 
is currently unknown how the COPI machinery mediates the targeting of certain 
proteins to the LD surface and further studies are necessary. 
 
5.4 Formation of lipid droplets 
In the most cited model of LD formation, newly synthesized TGs accumulate in the 
lipid bilayer of the ER creating a fat lens between the leaflets of the ER membrane. 
The formation of TG drives the budding of nascent cytosolic LDs or, in cells that 
secrete TG, nascent lipoproteins (Figure 5). Lipoproteins are a mixture of proteins 
and lipids. The proteins serve to emulsify the lipid molecules. This allows the 
transport of fat through the aqueous environment of the cell and enables the 
secretion of fat out of the cell. The precise mechanism by which TGs are deposited 
into LDs is unknown. It is also unknown how the directionality of LD formation is 
achieved. Likely perilipin proteins such as perilipin3, which have been shown to bind 
very early to forming LDs, give directionality. Further it is unknown if the newly 
formed LDs stay connected or get detached from the ER. Surprisingly, genome-wide 
RNAi screens in Drosophila melanogaster or Saccharomyces cerevisiae have failed 
to identify proteins essential for LD formation. This suggests a protein-independent 
mechanism where LD formation is driven by emulsification. On the contrary, many 
proteins have been identified to be important for proper LD morphology. One 
example is seipin, a protein associated to congenital generalized lipodystrophy type 2 
in human. The absence of seipin in yeast leads to “super sized” LDs. In addition to 
the first model, in which the release of TG between the two leaflets of the ER 
membrane drives LD formation, three alternative models have been proposed. The 
first model is the bicelle formation model, which predicts that LDs are excised from 
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both leaflets of the ER membrane bilayer as a bicelle (Ploegh, 2007). The second 
model is the vesicular budding model, in which LDs are initially formed within small 
bilayer vesicles harboring TG synthesis enzymes (Walther and Farese, 2009). The 
third model is the “eggcup” model, in which an ER enclosed LD forms through 
transport of TG from the ER to the LD (Robenek et al., 2006). 
 
Figure 5: Different models of lipid droplet formation.  a) LDs form by releasing TG in between the 
two leaflets of the ER membrane. b) LDs are formed in the ER similar to a) but are consequently 
excised from the membrane. c) LDs are formed from small bilayer vesicles. d) Enclosed LDs form by 
transporting TG and phospholipids from the adjacent organelle to the forming LD. 
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5.5 TG synthesis pathway 
The driving force of de novo LD formation is the synthesis of neutral lipids such as 
TG. TG is synthesized when excess energy in form of fatty acids is available. Cells 
can absorb these fatty acids by passive diffusion or actively by fatty-acid transport 
and fatty-acid translocase proteins (Ehehalt et al., 2006; Schaffer and Lodish, 1995). 
To store the absorbed fatty acids in the form of TG they are activated to allow the 
esterification with glycerol. This is achieved through conjugation of fatty acids to 
coenzyme A forming fatty acyl-CoA. This reaction is energy-dependent (one ATP per 
conjugation) and is catalyzed by long-chain acyl-CoA synthetases (ACSLs) (Ellis et 
al., 2010). In the ER, de novo TG synthesis occurs in four sequential steps catalyzed 
by glycerol-3-phosphate O-acyltransferase (GPAT), 1-acylglycerol-3-phosphate O-
acyltransferase (AGPAT), phosphatidic acid phosphatase (PAP), and acyl-
CoA:diacylglycerol O-acyltransferase (DGAT) enzymes (Figure 6). For the four 
classes of TG synthesis enzymes many isoforms exist with different tissue 
expression and biological function.  
 
Figure 6: Pathway of TG synthesis. In the first step, catalyzed by GPATs, glycerol-3-phosphate 
(G3P) is esterified by a fatty acid coenzyme A ester to form lysophosphatidic acid (LPA). This is in turn 
acylated by AGPAT enzymes to from phosphatidic acid (PA), a precursor of the phospholipids PI, PG, 
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CL, and in yeast PS. PAP enzymes subsequently remove the phosphate group to form 1,2-
diacylglycerol (DG), which then allows acylation by DGAT enzymes and the formation of triacylglycerol 
(TG). DG is also a precursor for the phospholipids PC, PE, and PS. Abbreviation: PI, 
phosphatidylinositol; PG, phosphatidylglycerol; CL, cardiolipin; PS, phosphatidylserine; PC, 
phosphatidylcholine; PE, phosphatidylethanolamine; GPAT, glycerol-3-phosphate O-acyltransferase; 
AGPAT, 1-acylglycerol-3-phosphate O-acyltransferase; PAP phosphatidic acid phosphatase; DGAT, 
acyl-CoA:diacylglycerol O-acyltransferase. 
 
5.5.1 GPAT family 
The first and rate-limiting step in de novo TG synthesis is catalyzed by GPAT 
enzymes (Coleman and Lee, 2004). This enzyme class converts glycerol-3-
phosphate and fatty acyl-CoA to 1-acylglycerol-3-phosphate (lysophosphatidate). In 
recent studies four mammalian GPAT isoforms have been identified (GPAT1-4). 
GPAT1 and GPAT2 localize to the mitochondrial outer membrane, whereas GPAT3 
and GPAT4 localize to the ER (Wendel et al., 2009). In most tissues microsomal 
GPAT accounts for 90% of total GPAT activity. In liver, however, both microsomal 
GPAT (50–80% of total activity) and mitochondrial GPAT (20-50% of total activity) 
are expressed and active (Coleman and Lee, 2004). 
 
5.5.2 AGPAT family 
The second step of de novo TG synthesis is catalyzed by AGPAT enzymes, which 
convert 1-acylglycerol-3-phosphate and fatty acyl-CoA to 1,2-diacylglycerol-3-
phosphate (phosphatidic acid). AGPAT activity has been found in mitochondrial and 
microsomal, as well as in plasma membrane fractions (Coleman and Lee, 2004). Due 
to sequence homology to known AGPAT enzymes from yeast and E.coli six different 
AGPATs have been identified in humans. The enzymatic activity for AGPAT1 and 
AGPAT2 has been experimentally confirmed and both these enzymes localize to the 
ER. In contrast, AGPAT3 localize to the Golgi (Schmidt and Brown, 2009) and 
AGPAT5 is suggested to localize to mitochondria (Prasad et al., 2011). The enzymes 
AGPAT3-5 show very low activity when compared to AGPAT2 suggesting that they 
may have different substrate specificity (Lu et al., 2005).  
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5.5.3 PAP family 
The product of the AGPAT catalyzed reaction, phosphatidate, is a key molecule in 
lipid biosynthesis that serves as a precursor for all glycerophospholipids (Kent, 
1995). It can be converted to CDP-diacylglycerol, a precursor of phosphatidylinositol, 
phosphatidylglycerol, cardiolipin, and in yeast to phosphatidylserine (Figure 6). 
Phosphatidate can also be dephosphorylated by PAP enzymes to produce 
diacylglycerol. Diacylglycerol is a precursor for the synthesis of TG, 
phosphatidylserine (in higher eukaryotes), phosphatidylcholine and 
phosphatidylethanolamine (Figure 6). Both soluble as well as membrane-associated 
fractions contain PAP activity (Kent, 1995). Membrane-associated PAP activity is 
associated with microsomal and plasma membrane fractions. Two PAP isoforms, 
known as PAP-1 and PAP-2, have been identified. PAP-1 is involved in TG and 
phospholipid synthesis whereas PAP-2 activity is important for signal transduction 
pathways at the plasma membrane. In mammals, three PAP-1 homologues Lipin1, 2, 
and 3 exist.  
 
5.5.4 DGAT family 
The final step of TG synthesis is catalyzed by DGAT enzymes, which covalently 
attach a third fatty acyl-CoA to a DG molecule to form TG and CoA (Coenzyme A). 
Two isoforms of DGAT enzymes exist in mammals: DGAT1 and DGAT2, which are 
different at a sequence level. Due to the localization of both enzymes to the ER it is 
believed that TG synthesis mainly occurs at the ER (Yen et al., 2008). DGAT2 has a 
higher affinity for its substrates than DGAT1 and is therefore more active at lower 
fatty acid concentrations than DGAT1. In contrast to DGAT2, DGAT1 has multiple 
acyltransferase activities using a broad spectrum of lipids as fatty acyl acceptors 
such as DG, monoacylglycerol, long-chain alcohols, and retinol. Both enzymes are 
integral membrane proteins with different membrane topology. DGAT1 is predicted to 
be a multiple spanning transmembrane domain and forms homotetramers (Yen et al., 
2008). Mammalian DGAT2 contains two transmembrane domains or one single long 
hydrophobic region (aa 66–115) at the N-terminus that is embedded in the 
membrane bilayer (Yen et al., 2008). The subcellular localization of DGAT enzymes 
appears to be different. In plant cells DGAT1 and DGAT2 localize to distinct 
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punctuated regions in the ER suggesting the existence of different ER subdomains 
for TG synthesis (Shockey et al., 2006). Interestingly, one of the plant homologues of 
the microsomal GPATs (GPAT9) has been identified to localize to the same ER 
subdomains as DGAT2. The different localization of DGAT1 and DGAT2 within the 
ER suggests the existence of different complexes for TG synthesis in the ER (Gidda 
et al., 2011). The function of the different complexes is currently unknown. DGAT2 
has been further identified to localize in close proximity to the surfaces of LDs (Yen et 
al., 2008). It is currently under debate whether DGAT2 localizes to the LD surface or 
if it localizes to ER subdomains that are in very close proximity to the LD. The 
hairpin-like transmembrane domain of DGAT2 would allow targeting of DGAT2 to the 
surface of LDs. Recent data from the yeast homologue Dga1 support this model 
(Jacquier et al., 2011). 
 
5.6 Expansion of the lipid droplet core 
Cells are able to expand existing LDs to store more TG in LDs. This requires local 
synthesis or transfer of TG from the ER to LDs. The localization of DGAT2 to LDs 
during fatty acid loading (Yen et al., 2008) (supplementation of oleate to the culture 
medium) is a hint that local synthesis of TG might occur on LDs in vivo. It is currently 
unknown if the proximal steps in TG synthesis also happen on LDs. If LDs are 
connected with the ER at all time, channeling of TG to LDs through membrane 
connections could be possible. Alternatively, transport proteins could transfer TG 
from the ER to the core of LDs. This has been shown in the case of nascent 
lipoproteins, where the microsomal triacylglycerol transfer protein (MTP) transfers 
lipids by a shuttle mechanism (Atzel and Wetterau, 1993). First, MTP binds the ER 
membrane and extracts individual lipids. Then, MTP dissociates from the ER 
membrane and diffuses to an acceptor membrane to deposit its bound lipid. Such a 
mechanism would be possible for cytosolic LDs but no lipid transfer proteins have 
been identified. LDs could expand alternatively or additionally by coalescence of 
small LDs to bigger ones. Recent work suggests that the fat-specific protein of 27 
kDa (FSP27), a member of the cell death-inducing DFF45-like effector C (CIDEC) 
family, is involved in catalyzing LD fusion by transferring lipids between two adjacent 
LDs (Gong et al., 2011). This model is supported by the localization of FSP27 to LD-
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LD contact sites (Gong et al., 2011). Overexpression of FSP27 in cells leads to 
increased LD size (Puri et al., 2007). However, CIDE proteins are not expressed in 
all tissues and FSP27 is mostly restricted to adipocytes. Some organisms, such as 
Drosophila melanogaster and Caenorhabditis elegans, lack CIDE proteins completely 
but expansion of LDs has still been observed. This suggests that FSP27 mediated 
LD fusion cannot provide a general mechanism for LD expansion. Another study has 
suggested that SNARE (soluble N-ethylmaleimide-sensitive factor attachment 
receptor proteins) proteins mediate homotypic fusion between LDs (Bostrom et al., 
2007). Knockdown of genes encoding SNAP23, syntaxin-5, and VAMP4 decreased 
the rate of LD fusion in mouse embryonic fibroblast NIH 3T3 cells (Bostrom et al., 
2007). The classical role of SNARE proteins is to mediate homotypic fusion of 
bilayer-bounded vesicles with organelles. However, it is unclear how SNARE proteins 
could mediate fusion of two monolayers, and more mechanistic insights are 
necessary. In most cell types (besides in adipocytes) fusion of LDs is a rare event 
and therefore other mechanism are more likely important for LD expansion. 
 
5.7 Expansion of the lipid droplet surface 
Within a few hours LDs can expand rapidly and often their diameter increases more 
than 3 times leading to a more than 10 times increase in surface area. This increase 
in area needs to be covered by phospholipids to prevent coalescence of LDs. The 
most abundant phospholipids in the LD monolayer are PC and PE. Between these 
two phospholipids, PC is key for coating LDs and preventing their coalescence. The 
expansion of the LDs leads to an increased need of PC on the surface of LDs. In 
most cells, PC and PE are synthesized by an aminoalcoholphosphotransferase 
reaction, which uses DG and the activated form CDP-choline or CDP-ethanolamine, 
respectively. This biosynthetic pathway is called the Kennedy pathway and named 
after Eugene Kennedy who discovered it in 1956 together with his graduate student 
Samuel Weiss (Kennedy and Weiss, 1956). Synthesis of PC consists of three 
enzymatic steps. In the first step, choline kinase (CK) catalyzes the ATP-dependent 
phosphorylation of choline, forming phosphocholine, and ADP. In the second and 
rate-limiting step of the Kennedy pathway (Sundler and Akesson, 1975), CCT uses 
PC and cytidine triphosphate (CTP) to form the high-energy donor CDP-choline with 
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the release of pyrophosphate. CDP-choline:1,2-diacylglycerol cholinephospho-
transferase (CPT) catalyzes the final reaction of the pathway, using CDP-choline and 
DG to form PC and CMP as byproducts. Depending on the cell type PC can be 
alternatively synthesized by conversion of PE into PC through three sequential 
methylations of the ethanolamine head group and phosphatidylethanolamine N-
methyltransferase (PEMT) enzymes catalyze this reaction. PE is synthesized in a 
series of similar reactions except that ethanolamine is used instead of choline (Figure 
7). Alternatively PE can be synthesized via decarboxylation of PS (Schuiki and 
Daum, 2009). The contribution of this pathway is organism- and cell type-dependent 
(Gibellini and Smith, 2010). Little is known how the need for phospholipids on 
growing LDs is sensed and how these phospholipids are consequently targeted to 
LDs. A genome-wide RNAi (RNA-interference) screen in Drosophila S2 cells 
identified genes important for LD morphology. Depletion of CK and CCT decreased 
LD number but increased LD size suggesting a fusion of LDs under these conditions 
due to decreased PC levels (Guo et al., 2008). The rate-limiting enzyme in the 
Kennedy pathway, CCT, is mainly regulated by translocation of the inactive protein 
from the cytoplasm to cellular membranes causing its activation. Binding of the 
amphipathic α-helix to the membrane activates CCT by relieving an inhibitory 
restraint in the catalytic domain (Friesen et al., 1999). Further it has been shown that 
CCT binding is increased for anionic membranes or membranes enriched in DG or 
PA. Binding is also enhanced when cellular membranes are “PC deficient” due to the 
overexpression of phospholipase D or depletion of choline (Kent, 2005). But the 
exact mechanism that triggers CCT translocation is still unknown. CCTs exist in two 
isoforms in most eukaryotes (CCT1 and CCT2 in Drosophila melanogaster). The 
primary structure is made up of four functional domains, the N-terminal nuclear 
localization signal, a catalytic core, a lipid-binding domain (long amphipathic a-helix) 
and a C-terminal phosphorylation domain (Gibellini and Smith, 2010). 
Phosphorylation and dephosphorylation of CCT is suggested to fine tune the 
membrane affinity of CCT. The soluble, inactive form of CCT is highly 
phosphorylated, whereas translocation to membranes is followed by 
dephosphorylation (Kent, 2005). Interestingly, both isoforms localize to the surface of 
LDs suggesting a role in PC homeostasis on LDs. How CK and CCT are regulated to 
maintain PC homeostasis on LDs during expansion is unknown. 
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Figure 7: The Kennedy pathway. PC and PE are synthesized in three reactions from 
choline/ethanolamine. In the first step choline/ethanolamine are phosphorylated which are then used 
in the second step to form the activated form CDP-choline/ethanolamine. In the final step the activated 
head groups are bound to DG to form PC or PE. Abbreviation: Cho, choline; Cho-P, phosphocholine; 
CDP-Cho, cytidine-diphosphocholine; Etn, ethanolamine; Etn-P, phosphoethanolamine; CDP-Etn, 
cytidine-diphosphoethanolamine; PC, phsphatidylcholine; PE, phosphatidylethanolamine; DG, 
diacylglycerol; CK, choline kinase; CCT, CTP:phosphocholine cytidylyltransferase; CPT, CDP-
choline:1,2-diacylglycerol cholinephosphotransferase; EK, ethanolamine kinase; ECT, 
CTP:phosphoethanolamine cytidylyltransferase; EPT, CDP-ethanolamine:1,2-diacylglycerol 
ethanolaminephosphotransferase. 
 
5.8 Breakdown of lipid droplets - Intracellular lipolysis 
In times when energy or lipids are needed cells are able to metabolize the stored 
energy by hydrolysis of TG into glycerol and fatty acids. The hydrolysis of TG 
requires three consecutive steps and the activity of at least three different enzymes in 
mammals (Zechner et al., 2012). The first step is catalyzed by ATGL, converting TG 
into DG and a fatty acid. HSL catalyzes the second step, in which a second fatty acid 
is removed to yield monoacylglycerol (MG). MG is subsequently hydrolyzed by MG 
lipase (MGL) producing glycerol and another fatty acid (Figure 8). Due to low 
abundance of ATGL and HSL in some non-adipose tissues other lipases might be 
involved in hydrolysis of TG. Intracellular lipolysis is a strongly regulated process.  
Lipolysis has mostly been studied in adipocytes and occurs according to a slightly 
different mechanism in oxidative tissue, where perilipin1 is absent. In adipocytes, 
lipolysis is stimulated during fasting by the catecholamine norepinephrine, which 
activates beta-adrenergic receptors coupled to G-proteins on the plasma membrane. 
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This stimulates adenylyl cyclase to generate cyclic AMP (cAMP). cAMP binds 
subsequently PKA (protein kinase A) increasing the activity of the enzyme (Duncan 
et al., 2007). Activation of PKA is an important step for the regulation of different 
proteins involved in intracellular lipolysis. PKA catalyzes the phosphorylation of 
perilipin1 at multiple sites. This causes the release of the bound coactivator protein 
CGI-58 from perilipin1, fully inducing ATGL’s hydrolysis activity (Zechner et al., 
2012). ATGL is further regulated on a transcriptional level as well as by the peptide 
inhibitor G0S2 (Zechner et al., 2012). PKA also phosphorylates HSL directly on 
multiple sites. This causes activation of HSL and subsequent translocation of the 
lipase from the cytosol to LDs. Interestingly, recent studies have shown that 
phosphorylated HSL binds to PKA phosphorylated perilipin1, thereby gaining access 
to the hydrophobic core of LDs (Miyoshi et al., 2007; Shen et al., 2009; Wang et al., 
2009). 
 
Figure 8:  Model for fasting stimulated lipolysis in adipose tissue. The process requires three 
enzymes: ATGL cleaves the first esterbond in TGs, HSL hydrolyzes DGs, and MGL MGs. ATGL 
interacts with its coactivator protein CGI-58 for full activity. Phosphorylated HSL translocates to the 
LD, and interacts with phosphorylated PLIN-1 (adapted from Zechner et al., 2012). Abbreviations: TG, 
triacylglacerol; DG, diacylglycerol; MG, monoacylglycerol; G, glycerol; ATGL, adipose triglyceride 
lipase; CGI-58, comparative gene identification-58; HSL, hormone-sensitive lipase; MGL, 
monoglyceride lipase; PLIN-1, perilipin-1. 
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The free fatty acids are subsequently converted to fatty acid CoA by ACSL enzymes 
and imported to the mitochondria for beta-oxidation. Activated fatty acids with chain 
length shorter than 10 carbons can diffuse through the inner mitochondrial 
membrane. Activated fatty acids with more than 10 carbon atoms are bound to 
carnitine in a reaction catalyzed by carnitine acyltransferase I and transported across 
the inner mitochondrial membrane via carnitine-acylcarnitine translocase (Indiveri et 
al., 2011). In the mitochondrial matrix, acylcarnitine is converted back to fatty acid 
CoA and carnitine by carnitine acyltransferase II. 
A recent study by Singh and colleagues reported compelling evidence linking 
lipolysis to macroautophagy in starved hepatocytes (Singh et al., 2009). In this 
alternative lipolytic process, whole LDs can be encapsulated in double-membrane 
vesicles (autophagosome), which then fuse with lysosomes for degradation. The 
contribution of autophagy for lipid homeostasis is currently controversial.  
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6 Abstract of publications 
For copyright reasons, full text versions of the publications are not included in the 
online version of this thesis. Please follow the links to download pdf files directly from 
the publisher’s website. In the printed version reprints of the papers are found in the 
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6.1 Publication I 
 
Phosphatidylcholine synthesis for lipid droplet expansion is mediated by 
localized activation of CTP:phosphocholine cytidylyltransferase 
Krahmer N., Guo Y., Wilfling F., Hilger M., Lingrell S., Heger K., Newman H.W., 
Schmidt-Supprian M., Vance D.E., Mann M., Farese R.V. Jr, Walther T.C 
Cell Metabolism, 14(4): 504-15  (2011). 
Link to pdf 
 
Abstract 
Lipid droplets (LDs) are cellular storage organelles for neutral lipids that vary in size 
and abundance according to cellular needs. Physiological conditions that promote 
lipid storage rapidly and markedly increase LD volume and surface. How the need for 
surface phospholipids is sensed and balanced during this process is unknown. Here, 
we show that phosphatidylcholine (PC) acts as a surfactant to prevent LD 
coalescence, which otherwise yields large, lipolysis-resistant LDs and triglyceride 
(TG) accumulation. The need for additional PC to coat the enlarging surface during 
LD expansion is provided by the Kennedy pathway, which is activated by reversible 
targeting of the rate-limiting enzyme, CTP:phosphocholine cytidylyltransferase 
(CCT), to growing LD surfaces. The requirement, targeting, and activation of CCT to 
growing LDs were similar in cells of Drosophila and mice. Our results reveal a 
mechanism to maintain PC homeostasis at the expanding LD monolayer through 
targeted activation of a key PC synthesis enzyme. 
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6.2 Publication II 
 
Triacylglycerol synthesis enzymes mediate lipid droplet growth by relocalizing 
from the ER to lipid droplets. 
Wilfling F., Wang H., Haas J.T., Krahmer N., Gould T.J., Uchida A., Cheng J.X., 
Graham M., Christiano R., Fröhlich F., Liu X., Buhman K.K., Coleman R.A., 
Bewersdorf J., Farese R.V. Jr, Walther T.C. 
Developmental Cell, 24(4): 384-99 (2013). 
Link to pdf 
 
Abstract 
Lipid droplets (LDs) store metabolic energy and membrane lipid precursors. With 
excess metabolic energy, cells synthesize triacylglycerol (TG) and form LDs that 
grow dramatically. It is unclear how TG synthesis relates to LD formation and growth. 
Here, we identify two LD subpopulations: smaller LDs of relatively constant size, and 
LDs that grow larger. The latter population contains isoenzymes for each step of TG 
synthesis. Glycerol-3-phosphate acyltransferase 4 (GPAT4), which catalyzes the first 
and rate-limiting step, relocalizes from the endoplasmic reticulum (ER) to a subset of 
forming LDs, where it becomes stably associated. ER-to-LD targeting of GPAT4 and 
other LD-localized TG synthesis isozymes is required for LD growth. Key features of 
GPAT4 ER-to-LD targeting and function in LD growth are conserved between 
Drosophila and mammalian cells. Our results explain how TG synthesis is coupled 
with LD growth and identify two distinct LD subpopulations based on their capacity 
for localized TG synthesis. 
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6.3 Publication III 
 
Protein correlation profiles identify lipid droplet proteins with high confidence. 
Krahmer N., Hilger M., Kory N., Wilfling F., Stoehr G., Mann M., Farese R.V. Jr, 
Walther T.C.  
Molecular & Cellular Proteomics, 12(5): 1115-26 (2013).  
Link to pdf 
 
Abstract 
Lipid droplets (LDs) are important organelles in energy metabolism and lipid storage. 
Their cores are composed of neutral lipids that form a hydrophobic phase and are 
surrounded by a phospholipid monolayer that harbors specific proteins. Most well-
established LD proteins perform important functions, particularly in cellular lipid 
metabolism. Morphological studies show LDs in close proximity to and interacting 
with membrane-bound cellular organelles, including the endoplasmic reticulum, 
mitochondria, peroxisomes, and endosomes. Because of these close associations, it 
is difficult to purify LDs to homogeneity. Consequently, the confident identification of 
bona fide LD proteins via proteomics has been challenging. Here, we report a 
methodology for LD protein identification based on mass spectrometry and protein 
correlation profiles. Using LD purification and quantitative, high-resolution mass 
spectrometry, we identified LD proteins by correlating their purification profiles to 
those of known LD proteins. Application of the protein correlation profile strategy to 
LDs isolated from Drosophila S2 cells led to the identification of 111 LD proteins in a 
cellular LD fraction in which 1481 proteins were detected. LD localization was 
confirmed in a subset of identified proteins via microscopy of the expressed proteins, 
thereby validating the approach. Among the identified LD proteins were both well-
characterized LD proteins and proteins not previously known to be localized to LDs. 
Our method provides a high-confidence LD proteome of Drosophila cells and a novel 
approach that can be applied to identify LD proteins of other cell types and tissues. 
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6.4 Publication IV 
COPI buds 60-nm lipid droplets from reconstituted water-phospholipid-
triacylglyceride interfaces, suggesting a tension clamp function. 
Thiam A.R., Antonny B., Wang J., Delacotte J., Wilfling F., Walther T.C., Beck R., 
Rothman J.E., Pincet F.  
PNAS, 110(33): 13244-9 (2013) 
Link to pdf 
 
Abstract 
Intracellular trafficking between organelles is achieved by coat protein complexes, 
coat protomers, that bud vesicles from bilayer membranes. Lipid droplets are 
protected by a monolayer and thus seem unsuitable targets for coatomers. 
Unexpectedly, coat protein complex I (COPI) is required for lipid droplet targeting of 
some proteins, suggesting a possible direct interaction between COPI and lipid 
droplets. Here, we find that COPI coat components can bud 60-nm triacylglycerol 
nanodroplets from artificial lipid droplet (LD) interfaces. This budding decreases 
phospholipid packing of the monolayer decorating the mother LD. As a result, 
hydrophobic triacylglycerol molecules become more exposed to the aqueous 
environment, increasing LD surface tension. In vivo, this surface tension increase 
may prime lipid droplets for reactions with neighboring proteins or membranes. It 
provides a mechanism fundamentally different from transport vesicle formation by 
COPI, likely responsible for the diverse lipid droplet phenotypes associated with 
depletion of COPI subunits. 
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7 Unpublished data 
7.1 Results  
The COPI machinery modulates LD surfaces to mediate protein targeting 
Unbiased genome-wide screens in model systems, such as Drosophila cells, 
revealed factors that are required for LD targeting of proteins (Beller et al., 2008; Guo 
et al., 2008). Specifically, members of the Arf1/COPI machinery, but not other 
proteins involved in secretory trafficking (e.g., COPII or clathrin), are required for 
normal LD morphology and for targeting of some proteins (Beller et al., 2008; Guo et 
al., 2008; Soni et al., 2009). Depletion of Arf1/COPI proteins from cells leads to the 
formation of uniformly sized, lipolysis-resistant LDs that lack the major adipose TG 
lipase (ATGL). How Arf1/COPI proteins function in LD biology and protein targeting is 
unknown. 
To investigate the mechanism of Arf1/COPI-mediated LD protein targeting, I tested 
the scope of proteins requiring this machinery. Consistent with previous reports 
(Beller et al., 2008; Soni et al., 2009), I found that brummer (Drosophila ATGL 
homologue) localization to LDs was greatly reduced and shifted to the cytoplasm in 
cells lacking Arf79F (Drosophila Arf1) or COPI proteins (Figure 9a). The Arf1/COPI 
machinery is not required for all proteins to access to LDs: I found no difference in 
the targeting of Lsd1 (a perilipin orthologue) to LDs in Arf1/COPI-depleted cells 
(Figure 9b). Specific enzymes involved in TG synthesis, including the rate-limiting 
enzyme glycerol-phosphate acyltransferase 4 (GPAT4), contain a membrane-
embedded hairpin motif that mediates their localization to surfaces of expanding LDs 
(Wilfling et al., 2013). Similar to brummer, GPAT4 required Arf1/COPI and garz 
(Drosophila GBF1 homologue, a GTP exchange activator of Arf1) to target a subset 
of LDs. Without them, GPAT4 remained in the ER (Figure 9c). In agreement with 
previous reports (Beller et al., 2008; Guo et al., 2008), depletion of each subunit of 
COPI except εCOPI had a similar effect on GPAT4 LD targeting and LD morphology. 
GPAT4 targeting to LDs is required to convert smaller LDs into expanded LDs 
(Wilfling et al., 2013). In agreement with this function of GPAT4 targeting, I found that 
LDs in Arf1/COPI-depleted cells had monodisperse size and lacked large, expanded 
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LDs. LDs of Arf1/COPI depleted cells were slightly larger than the smaller, non-
expanded population of LDs in control cells (Figure 9d), likely due to the lack of 
brummer and a consequent reduction of lipolysis rate at those LDs (Beller et al., 
2008; Guo et al., 2008). 
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Figure 9: The COPI machinery is required for LD targeting of specific proteins. a) brummer LD 
targeting in S2 cells is dependent on Arf1/COPI. GFP-brummer localizes to LDs stained with lipidtox 
(top panel). GFP-brummer LD targeting is abolished in the absence of either Arf79F (middle panel) or 
βCOP (bottom panel). b) Lsd1 LD targeting is independent of Arf1/COPI. Cherry-Lsd1 localizes to LDs 
stained with BODIPY in the absence of Arf179F (middle panel) or βCOP (bottom panel). c) Targeting 
of GPAT4 from the ER to LDs depends on Arf1/COPI. Endogenous GPAT4 detected by 
immunofluorescence localizes to LDs (stained by BODIPY) in control treated cells, but not in the 
absence of COPI machinery subunits, except eCOP. d) The bimodal size distribution of control cells 
(black line) with few large LDs and many small LDs is changed to a monodisperse size in Arf1/COPI-
depleted cells (orange and red line). Scale bars are 10 µm (overview) or 1 µm (inlay). 
 
How do Arf1/COPI proteins act in targeting proteins to LDs? The canonical function 
of Arf1/COPI in mediating vesicle trafficking at the Golgi suggests these proteins 
might form vesicles that carry protein cargos to LDs. Alternatively, Arf1/COPI might 
act directly at the LD monolayer surface, budding off a “nano-LD”, thus removing 
primarily phospholipids and allowing for protein access to LDs. These models can be 
distinguished by determining the site of Arf1/COPI action (i.e., donor membrane 
bilayers or the LD surface). I thus localized COPI with a specific antibody against 
βCOP, β‘COP, and GBF1 (the mammalian garz homologue GTPase exchange factor 
activating Arf1) with respect to LDs in mammalian NRK cells, for which more 
antibodies are available than for Drosophila cells (Figure 10a and Suppl. Fig. 1a). As 
expected, I found strong βCOP, β‘COP, and GBF1 signals in the perinuclear region 
of cells, likely representing the Golgi apparatus (Suppl. Fig 1c). Additionally, I 
consistently found βCOP, β’COP, or GBF1 foci in close proximity to LDs and 
colocalized with the LD marker protein perilipin3 (Figure 10a,c and Suppl. Fig. 1b). 
LD colocalization was specific for βCOP and GBF1, as the Golgi marker GM130 was 
not detected at LDs (Figure 10b). To further determine whether colocalization was 
specific to LDs or due to overlapping signals at LDs and peripheral Golgi-derived 
vesicles, I compared the experimental distributions of βCOP around LDs with the 
random distributions of foci around LDs. I found significantly more COPI spots 
colocalized with LDs in the experiment than expected from a random distribution 
(Figure 10a). This effect was specific for COPI; other trafficking complexes of the 
Golgi apparatus, such as clathrin, showed a decreased number of foci around LDs. 
Importantly, I also found the KDEL receptor cargo of the Arf1/COPI machinery 
excluded from LD-localized β‘COP foci (Figure 10b). Similar localization results were 
obtained for the localization of αCOP and garz in Drosophila S2 cells (Figure 10d). 
Together with previous proteomic and cell biological results (Bartz et al., 2007b; 
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Ellong et al., 2011; Nakamura et al., 2005), these data show localization of the COPI 
machinery on LDs.  
 
Figure 10: The COPI machinery localizes to the LD surface. a) The endogenous COPI machinery 
localizes to LDs in NRK cells. NRK cells stained for βCOP or GBF1 by immunofluorescence (red) 
show partial colocalization with LDs stained with BODIPY (green). βCOP colocalization with LDs in 
NRK cells is not random. Relative frequencies of βCOP, KDEL receptor and clathrin spots colocalizing 
with LDs in experiments are determined and respectively compared to the frequencies of 
colocalization from a binomial random distribution. From the two frequencies (experiment vs. 
simulation) a significant overrepresentation of βCOP on LDs is observed, whereas clathrin and KDEL 
receptor (KDELR) are not found on LDs. b) Golgi GM130 or KDELR (green) are excluded from LD 
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localized COPI (red). c) β'COP (green) localizes to the surface of (perilipin3, red) by confocal (upper 
panel) and super-resolution STED microscopy (lower panel). Scale bar=500nm (overview) or 100nm 
(inlay). d) The endogenous COPI machinery stained with αCOP or garz (red) antibodies localizes to 
LDs in S2 cells. Frequencies of colocalization of αCOP and garz spots with LDs from experiments are 
higher than expected from a random distribution. Statistical significance was tested by a student t-test 
with P<0.01 (n=30). Scale bars in (a), (b), and (d) are 10µm (overview) or 1µm (first inlay) or 250nm 
(second inlay) 
 
If Arf1/COPI acts directly on LDs to remove primarily phospholipids, reducing LD 
coverage by another method should rescue the defect of GPAT4 targeting in cells 
missing Arf1/COPI. I tested this strong prediction by co-depleting Arf1/COPI proteins 
and CCT1 from cells. CCT1 is the rate-limiting enzyme of PC synthesis, required for 
PC synthesis to cover LDs during their expansion. In its absence, LDs become 
deficient in PC, leading them to coalesce over time and to yield few very large LDs 
(Krahmer et al., 2011). As expected, depletion of Arf1 or βCOP, but not CCT1, led to 
the absence of GPAT4 from LDs (Figure 11a). As predicted from the model that 
Arf1/COPI proteins act to remove phospholipids from LDs, efficient co-depletion of 
these proteins with CCT1 rescued the GPAT4 targeting defect (Figure 11a and 
Suppl. Fig. 2). Importantly, this effect was not due to a general restoration of 
Arf1/COPI function. Either Arf1/COPI depletion or co-depletion of Arf1/COPI and 
CCT1, but not CCT1 depletion alone, greatly reduced the secretion of a horseradish 
peroxidase containing a signal sequence that was used previously to unravel the 
secretory pathway of Drosophila cells (Figure 11b) (Bard et al., 2006). These data 
reveal a function of Arf1/COPI in controlling LD phospholipid levels, separate from 
their function in secretory trafficking. To further investigate this possibility, I assayed 
the time course of LD targeting of CCT1, which we previously found to respond to PC 
deficiency (Krahmer et al., 2011). I found a significant delay of CCT1 targeting to LDs 
in βCOP-depleted cells (Figure 11c), indicating that under these conditions, LDs 
become PC-deficient later during expansion, likely due to relatively larger amounts of 
phospholipids on their surface. 
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Figure 11: Reduction of cellular PC levels rescues GPAT4 LD targeting in the absence of the 
COPI machinery. a) Endogenous GPAT4 (red) localizes to LDs (green) in control and CCT1, but not 
Arf1/COPI depleted cells. Efficient co-depletion of CCT1 and Arf1 or βCOPI restores targeting to LDs. 
b) Arf1/CCT1 or βCOP/CCT1 co-depletion blocks HRP secretion. Error bars represent the s.d. of 
triplicate measurements c) Endogenous CCT1 (red) targeting to LDs (green) is delayed in cells 
depleted of bCOP. Ratios between nuclear and LD CCT1 signals are shown. Error bars represent the 
s.d. of the mean ratio from 100 cells. 
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If Arf1/COPI proteins function to remove phospholipids from LDs and thus allow 
proteins to bind, modulating the LD surface properties should similarly alter protein 
targeting to LDs. To test this hypothesis, I added PC to cells. Consistent with the 
hypothesis, PC addition was sufficient to prevent GPAT4 targeting to the LD surface 
(Figure 12a). In this instance, it presumably shields the TG core of LDs and lowers 
surface tension. I next determined if adding a surfactant with a low potential to shield 
TG and inducing higher surface tension would restore the GPAT4 targeting effect to 
LDs in the setting of Arf1/COPI depletion. I reasoned that cholesterol, with its small 
head-group and pronounced cone shape, would increase the surface tension of the 
LD oil-cytosol interface. In vitro measurements confirmed the cholesterol effect on 
the surface tension of TG-buffer interface in presence of phospholipids mimicking the 
LD surface (PC and PE) (Figure 12c), as did measurements of LD emulsion stability 
in the presence of cholesterol (Figure 12d). When cholesterol was added to 
Arf1/COPI-depleted cells, the cholesterol reached the LD surface (Suppl. Fig. 3a and 
b). Importantly, adding cholesterol to cells is sufficient to restore targeting of GPAT4 
to LDs in Arf1/COPI depleted cells (Figure 12a), and the number of GPAT4-positive 
LDs depends on the ratio of cholesterol and PC added to cells (Figure 12a). To test 
whether the effect is due to cholesterol’s physical properties or alternatively some 
physiological change in the cells, I repeated these experiments with the artificial lipids 
SR59230A and stearylamine.  SR59230A is an amphiphilic molecule that normally 
does not occur in cells, but which induces LD fusion (Murphy et al., 2010), likely by 
increasing their surface tension in vivo. Stearylamine on the otherhand is an aliphatic 
amine and decreases surface tension but leads to fusion of membranes likely by 
increasing the line tension. In agreement with findings with added cholesterol, adding 
SR59230A or sterylamine efficiently restored GPAT4 targeting to Arf1/COPI-depleted 
LDs (Figure 12b).  
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Figure 12: LD surface properties modulate GPAT4 LD targeting. a) Addition of exogenous PC to 
S2 cells inhibited GPAT4 LD targeting in βCOP or control RNAi treated cells. Cholesterol (chol) 
addition to cells restored GPAT4 LD targeting in βCOP-depleted cells. b) Targeting efficiency depends 
on the ratio of added cholesterol and PC in βCOP or control RNAi-treated cells. The artificial lipids 
SR59230A and sterylamine also rescued GPAT4 LD targeting in βCOP depleted cells. The numbers 
of GPAT4-targeted LDs per cell are shown. Error bars represent the s.d. from the mean number of 
GPAT4-targeted LDs in 40 cells. Statistical significance was calculated using ANOVA followed by a 
Dunnett test with a 99% confidence interval (p=0.01). c) Cholesterol increases the surface tension of 
PC/PE monolayer at a TG/buffer interface. Surface tension was measured by a drop weight method 
for the indicated phospholipid/cholesterol ratios. Error bars represent the s.d. of the mean from a 
minimum of 15 experiments. d) Cholesterol decreases the stability of artificial oil microdroplets in 
buffer. Time course of the optical density evolution of TG droplets with PC/PE and increasing amounts 
of cholesterol is shown. Error bars represent the s.d. of the mean from six independent experiments.  
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To further test whether changes of LD surface properties are sufficient to control 
GPAT4 targeting to LDs, I reconstituted this reaction in vitro with a microfluidic device 
(Suppl. Fig. 4). I introduced microsomes harboring GPAT4 fused to fluorescent GFP 
protein into buffer-in-oil micro-reactors (Figure 13). Mixing the content of the micro-
reactors by flow through zig-zagging micro-channels led to localization of some 
GPAT4 to the monolayer delimiting the TG phase. The amount of GPAT4-GFP at the 
monolayer depended on its composition and varied according to the surface tension. 
Like the situation in cells, monolayers rich in cholesterol and having higher surface 
tension, bound GPAT4-GFP more efficiently than control monolayers composed of 
PC/PE (Figure 13). 
 
Figure 13: Cholesterol rich surfaces mediate fusion with ER microsomes. GPAT4 targeting to 
phospholipid monolayers depends on the surface tension. Buffer drops containing GPAT4-GFP-
labeled microsomes are formed in a microfluidics device by flow focusing. The buffer micro-reactors 
are surrounded by oil of different composition (TG containing PC/PE (0.25% ea.) or PC/PE (0.25% 
ea.) + 2% cholesterol, or cholesterol only (0.5%); concentrations are w/w compared to TG). Each 
formed buffer drop pass through a zigzag region where microsomes inside the buffer drop are 
constantly brought into contact with the monolayer at the oil interface (Richmond et al., 2011). Drops 
are arrested in a network of trapping chambers. In the presence of PC/PE, little GPAT4-GFP is 
targeted to the monolayer but stays in microsomes. Adding 2% cholesterol or cholesterol alone 
significantly increased the GPAT4-GFP signal on the monolayer. Shown is a quantification of the 
efficiency of relocalization of GPAT4 from microsomes to the monolayer interface. Bar=100 µm 
(device) or 25 µm (drop). 
 
My data suggest a previously unrecognized function for the Arf1/COPI machinery at 
LDs. I propose that the COPI machinery in cells localizes to LDs and operates to 
remove excess phospholipids from the surfaces of LDs, thereby increasing LD 
Unpublished data 
 
   49 
surface tension and allowing for the recruitment of proteins. Consistent with our 
microfluidics experiments, LDs activated by COPI machinery could fuse with the ER 
establishing a continuous bridge between the ER and LD monolayer that allows 
protein targeting, as has been observed in the case of GPAT4 (Wilfling et al., 2013). 
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7.2 Material and Methods 
Antibodies 
Rabbit polyclonal antibodies used: anti-GPAT4 (Wilfling et al., 2013), anti-CCT1 
(Wilfling et al., 2013), anti-GBF1 (BD Biosciences), anti-KDEL-receptor (KDELR; gift 
from Dr. J.E. Rothman; Yale University), anti-βCOP (gift from Dr. J.E. Rothman; Yale 
University), anti-perilipin3 (TIP47; Novus Biologicals), anti-αCOP (Abcam), anti-
GRP78/BiP (ET-21) (Sigma-Aldrich) and anti-garz (Wang et al., 2012) (gift from Dr. 
A. Paululat; University of Osnabrück). Mouse monoclonal antibodies used: anti-
GM130 (BD Biosciences), anti-tubulin (Sigma-Aldrich), anti-β’COP (gift from Dr. J.E. 
Rothman; Yale University), and anti-clathrin heavy chain (x22) (Thermo Scientific) 
antibody. The following secondary antibodies were used: Alexa Fluor® 568 goat anti-
rabbit (Invitrogen), Alexa Fluor® 488 goat anti-mouse (Invitrogen), ATTO 647N 
(STED) goat anti-rabbit (Active Motif), and goat anti-mouse STAR470SX (Abberior). 
Plasmid DNA Construction 
Full-length cDNA encoding CG5295 (brummer) and CG10374 (Lsd1) were obtained 
from the DGRC (https://dgrc.cgb.indiana.edu/) and subcloned into the 
pENTR™/SD/DTOPO vector (Invitrogen) and indicated destination expression 
vectors (actin promoter). The destination vectors used in this study are part of the 
Drosophila Gateway™ Vector Collection and are available from the DGRC 
(https://dgrc.cgb.indiana.edu/). 
Cell Culture and Transfection 
WT Drosophila S2 or stably transfected cells (pAGW-brummer or pACherryW-Lsd1) 
were cultured, treated with oleate, transfected and depleted by RNAi as described 
(Krahmer et al., 2011). Cells were analyzed four days after RNAi treatment. Table S1 
contains a list of primers to generate dsRNAs for RNAi. A segment of pBluescript 
backbone was used as the template for control RNAi. Expression of the ss-HRP 
construct was induced and the secretion assay was performed as previously 
described (Bard et al., 2006). If not otherwise indicated, cells were treated after RNAi 
treatment with 1mM oleate for 8h. Exogenous lipids (PC, or cholesterol, or 
PC/cholesterol) were added to Drosophila S2 cells at the second day of the RNAi 
treatment. The final concentration of these lipids in the growth medium was 5mM. On 
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the fourth day, medium was replaced by fresh medium containing 1mM oleate and 
LD formation was induced for 8h before cells were fixed. The artificial lipid SR59230A 
was added to RNAi treated cell during the last hour of oleate treatment to a final 
concentration of 100µM. NRK cells were cultured in DMEM with 10% FBS and 
antibiotics (100 units of penicillin and 100 µg of streptomycin per ml). Cells were split 
onto glass bottom plates and incubated in the culture media the day before imaging. 
LDs were induced by treatment with 0.5mM oleate for 2h prior to fixation and 
imaging. 
Lipid Droplet Size Measurements 
Cells were treated with 1mM oleate, stained with BODIPY, and subsequently imaged 
and measured as previously described (Wilfling et al., 2013). Density plots were 
computed using R (http://www.r-project.org/). 
Light Microscopy 
For live cell imaging and immunostaining, cells were prepared and imaged as 
previously described (Wilfling et al., 2013). The antibody dilution buffer used for 
immunostaining of perilipin3 in NRK cells did not contain detergent. The 
permeabilization buffer used for immunostaing of CCT1 in Drosophila S2 cells had a 
final concentration of 0.1% NP-40. Also, the buffer for first and secondary antibody 
dilution was detergent free. LDs were stained with 1µg/ml BODIPY (Invitrogen) or 
LipidTOX (Invitrogen) or 10mM of MDH(Yang et al., 2012). 
Surface tension measurements 
The surface tension of different lipids or lipid mixtures was measured using a drop 
weight method. A buffer solution (25mM HEPES-KOH at pH 7.4, 100mM KCl, 10mM 
MgCl2) containing different concentrations of phospholipids and/or cholesterol was 
formed in a TG oil phase. Buffer drops were slowly formed in the oil (at a flow rate of 
20µl/h) to allow dynamic interfacial equilibrium. At a critical size the drop detaches. 
For each concentration, movies of this process were taken using a 1394 Unibrain 
camera. From the inner diameter d of the injection tube (d=250µm), the surface 
tension is determined by mg/(π*d*f) where f is a Wilkinson geometric parameter 
correction that depends on the ratio between d and the radius of the detached drop 
and g is the gravity constant. The mass m of the drop was calculated according to 
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m=v*Δρ (v is the volume of the drop and Δρ is the volume mass difference between 
oil and buffer phases). 
Stability assay of oil microdroplets in aqueous solution 
2.5mg DOPE and 2.5mg DOPC (Avanti Polar Lipids) were solubilized in 250mg TG 
(Sigma-Aldrich) by sonication. Lipids were then mixed with buffer (25mM HEPES-
KOH at pH 7.4, 100mM KCl, 10mM MgCl2) in a ratio of 1/16 (oil/buffer) by vortexing 
and sonication for 5min using a Branson 3510 sonicator water bath. The emulsion 
was added to the indicated amounts of cholesterol and sonicated for 2min. The 
optical density of the emulsion was monitored over a time course of 2h in 1min 
intervals using a TECAN infinite M200.  
Microfluidic experiments 
The microfluidics device was fabricated following well-established soft lithography 
techniques. A wafer mold was made by lithography using a negative resin (SU8-
2035). The device was made of a poly-dimethylsiloxane polymer (PDMS), used to 
replicate the pattern on the mold and stuck on a glass cover slip. The height of the 
device is 58±5 µm. A buffer and oil stream are generated using a syringe pump. By 
flow focusing, defined buffer drops are generated in the oil stream. These buffer 
micro-reactors contained GFP-GPAT4 microsomes. The oil used was a mixture of 
TG with phospholipids and/or cholesterol (PC/PE each 0.25% (w/w); 
PC/PE/cholesterol 1/1/4 with 2% (w/w) cholesterol; cholesterol 0.5% (w/w); indicated 
lipid concentrations are compared to TG). To ensure the same frequency of 
interaction of the microsomes with the monolayer interface, the flow rate of the buffer 
and oil stream (150µl/h and 30µl/h) was kept constant for all experiments. 
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7.3 Supplementary Information 
 
Supplementary Figure 1: Endogenous COPI subunits specifically localize to LDs in NRK cells. 
a) NRK cells stained for β’COP by immunofluorescence (red) show partial colocalization with LDs 
stained with BODIPY (green). b) NRK cells co-stained for endogenous clathrin (green) and βCOP 
(red) show no colocalization (upper panel). NRK cells costained for endogenous βCOP (red) and 
β’COP (green) show colocalization in the same structures on LDs. Endogenous β’COP (green) 
colocalizes with the LD marker protein perilipin3 (red). LDs are visualized by MDH (blue). c) NRK cells 
co-stained for endogenous GM130 (green) and βCOP (red) show colocalization in the perinuclear 
region of cells, representing the Golgi apparatus. 
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Supplementary Figure 2: Depletion of COPI machinery components is efficient. Expression of 
indicated subunits were measured by quantitative real-time PCR. Primers used are listed in Table S2. 
The Mean ± s.d. of three experiments is shown. 
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Supplementary Figure 3: Exogenously added cholesterol is incorporated into cellular 
membranes and LDs. Total lipids from control or cholesterol-treated cells normalized to 200 µg of 
protein a) or isolated LD fraction normalized to 50 µg of protein b) were separate by TLC and stained 
using Hanessian's stain. The band intensity for PE, PC and cholesterol was measured from three 
biological replicates. Western blots show the purity of the LD fraction 
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Supplementary Figure 4: Schematic overview of the microfluidic device used for the 
reconstitution of GPAT4 targeting to LDs. The initial oil stream (containing TG, cholesterol and/or 
phospholipids) is split into two streams that flow perpendicularly to a buffer stream with GPAT4-GFP 
containing microsomes. “Flow focusing” the oil streams continuously pinches small buffer micro-
reactors with defined size into the oil stream. After formation, the micro-reactor enters a zigzag pattern 
that creates a chaotic flow inside the micro-reactor. This increases the contact of the encapsulated 
microsomes with the interfacial monolayer formed at the buffer micro-reactor phase and the 
surrounding oil. Micro-reactors are arrested in a network of trapping chambers after the zigzag, 
allowing imaging and analysis of the monolayer targeted GPAT4 population. 
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8 Discussion 
The visualization of the cell interior by electron microscopy (EM) has advanced the 
field of cell biology significantly. The structure of the cell revealed by EM is 
unexpectedly rich and surprisingly uniform for practically all eukaryotic cells. 
Eukaryotic cells are subdivided into functionally distinct, membrane-enclosed 
compartments called organelles. Each organelle contains its own set of proteins and 
specialized molecules important for their function. The fine structure of organelles like 
ER, mitochondria, or the golgi-complex was defined by Albert Claude, Christian de 
Duve, and George E. Palade, who were awarded with the Nobel Prize in 1974 for 
their findings. To understand the eukaryotic cell, it is important to know the function of 
each compartment, how molecules and proteins move between them, and how the 
compartments themselves are created and maintained. Proteins play an important 
role in creating and maintaining these compartments. Subcellular fractionation and 
mass spectrometry-based proteomics allow the characterization of the protein 
composition of organelle-enriched fractions. Today, protein catalogs are available for 
almost all cytoplasmic and nuclear organelles (Mann et al., 2013).  
In the last 10 years, LDs have received a lot of attention as a hallmark of metabolic 
disease and insulin resistance. Proteomic analysis of lipid droplets has yielded a 
comprehensive catalog of lipid droplet proteins and many LD proteomes in different 
organisms or cell lines have been described (Athenstaedt et al., 1999; Beilstein et al., 
2013; Beller et al., 2006; Brasaemle et al., 2004; Cermelli et al., 2006; Ding et al., 
2012a; Ding et al., 2012b; Fujimoto et al., 2004; Ivashov et al., 2013; Liu et al., 2004; 
Orban et al., 2011; Sato et al., 2006; Wan et al., 2007; Zhang et al., 2011; Zhang et 
al., 2012). Due to the high sensitivity of mass spectrometers and the difficulties 
inherent in purifying organelles to homogenity, the overlap between published 
proteomes is often very low and proteins likely to be contaminants have been 
identified (like ribosomes). Therefore it has been challenging to distinguish bona fide 
organellar proteins from those that are contaminating. To address this problem, new 
methods had to be developed. In 2003 protein correlation profiling (PCP) was 
described for the first time (Andersen et al., 2003). PCP is a quantitative approach for 
determining the purification profiles of proteins through a high-density sucrose 
centrifugation gradient. By comparing the correlation of profiles with known organelle 
Discussion 
 
   58 
markers, the subcellular localization of proteins can be determined (Andersen et al., 
2003). Therefore contaminants, which have a different profile, can be distinguished 
from bona fide organellar proteins.  
We described a high confidence LD-PCP proteome with a set of just over 100 LD 
proteins from Drosophila melanogaster S2 cells. For most of the tested proteins the 
localization to LDs could be confirmed by fluorescence microscopy, increasing our 
confidence in the methodology. This approach led to the identification of novel 
proteins with a possible function at LDs as well as previously known LD proteins, 
such as ATGL. Comparison of our LD-PCP proteome with published LD proteomes 
isolated from Drosophila larval fat body or total larvae LDs shows little overlap 
between identified proteins, most likely due to differences in cell types or the different 
amount of contaminants.  
Besides the well-characterized LD proteins, we found several interesting proteins 
with unknown LD function that have been identified before. One protein identified is a 
to this point uncharacterized protein with homology to lipases (CG9186), which has 
been recently described to be important for positioning of LDs and fat storage (Thiel 
et al., 2013). Other proteins identified are the lipid metabolism enzymes 
prenyltransferase (involved in dolichol synthesis) and fatty acid desaturase for which 
their function in LD biogenesis has to be determined. Also several proteins, 
previously not known to localize to LDs, have been identified. Among them is the 
uncharacterized protein CG17292 that has a lipase motif and is expressed in 
Drosophila oenocytes.  
Unexpectedly, many enzymes catalyzing the early steps of the N-linked protein 
glycosylation pathway were identified in the LD-PCP. Lipid-linked oligosaccharide 
biosynthesis is performed by a series of glycosylation events, catalyzed by 
glycosyltransferases of the ALG (asparagine linked glycosylation) family. The 
process is initiated by ALG7 N-acetylglucosamine-phosphate transferase adding 
GlcNAc-P to a dolichol-phosphate. The next GlcNAc residue is added by the ALG13 
and ALG14 protein complex. After that five mannose residues using GDP-Man are 
added. The first addition of mannose is catalyzed by ALG1. Subsequently the 
addition of the two branching mannose residues is catalyzed by ALG2, followed by 
elongation of the Man3GlcNAc2 by ALG11. This results in a Man5GlcNAc2 
oligosaccharide representing the final product of the cytoplasmic lipid-linked 
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oligosaccharide biosynthesis. In the following steps the glycolipid flips across the 
membrane in a yet poorly characterized reaction to function as a substrate for 
oligosaccharyltransferase, which transfers the glycan to asparagine residues of ER-
lumen exposed proteins. We have identified all the enzymes of the cytoplasmic 
pathway as specific LD proteins in the LD-PCP, except ALG7 (not identified). We 
also detected the suggested flippase Rft1, which may flip the glycolipid from the 
cytosol into the lumen, only in the lipid droplet fraction suggesting a strong 
enrichment. Taken all the localizations of all the proteins of this pathway into account, 
it suggests that both dolichol synthesis, as well as the later assembly of the lipid-
linked oligosaccharide happens on the surface of LDs. The very extended dolichol 
isoprenoid sidechains (with up to 90 carbons for Dol-18) might be much easier 
accommodated in the hydrophobic core of the LD then in the thinner ER bilayer.  
A second group of proteins enriched in the LD fraction were enzymes of the TG 
synthesis pathway. We found enzymes catalyzing the first three steps, GPAT, 
AGPAT and PAP, enriched in the LD fraction. Previously, these enzymes have been 
described to localize to the ER where they synthesize TG (Coleman and Lee, 2004; 
Nimmo, 1979). How TG, synthesized in the ER, is incorporated into the core of 
growing cytoplasmic LDs is unknown. The localization of a subset of these enzymes 
to LDs suggests the possibility of local TG synthesis on LDs.  
To test this hypothesis, we investigated the role of TG synthesis enzymes in LD 
formation and growth. We showed that cells form two classes of LDs during oleate 
loading. The first class contains expanding LDs that grow by addition of locally 
synthesized TG. For this reason, a subset of de novo TG synthesis enzymes moves 
along membrane bridges to the LD surface (Figure 14). Fluorescence microscopy 
confirmed that GPAT4 (CG3209), AGPAT3 (CG4729), and DGAT2 (CG1942) are 
localized to LDs in Drosophila S2 cells. These proteins share a hydrophobic domain 
structure that likely forms a hairpin and allows the re-localization of these enzymes 
from the bilayer of the ER to the monolayer of LDs. Enzymes of the TG synthesis 
pathway that are exclusively localized to the ER are missing this feature. In contrast, 
LDs of a second class that do not acquire these TG enzymes remain small after their 
initial formation (Figure 14). ER-only localized enzymes are likely important for the 
formation of this class of LDs.  
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Figure 14: Model for the generation of the two different LD populations. ER-resident TG 
synthesis enzymes generate small static LDs (sLDs). Re-localization of a subset of TG synthesis 
enzymes mediates LD growth by local TG synthesis and leads to the formation of expanding LDs 
(eLDs). 
 
Under basal growing conditions the LD-localized TG synthesis enzymes are found in 
the ER. During formation, a subset of LDs is targeted by these enzymes and 
consequently grows. This observation leads to two main questions: How do these 
proteins localize to LDs and how is this process coordinated? Focusing on GPAT4, 
catalyzing the first and rate-limiting step in TG biosynthesis, we investigated the 
process of re-localization in more detail. Instead of re-localizing GPAT4 from the ER 
to LDs it is possible that newly synthesized GPAT4 is directly targeted to LDs 
whereas the ER pool of GPAT4 is degraded. Blocking protein synthesis did not affect 
the targeting of GPAT4 to LDs suggesting that the ER pool of GPAT4 can be re-
localized to LDs even in the absence of newly synthesized proteins.  
Unbiased genome-wide screens in Drosophila cells have revealed that the COPI 
machinery is required for LD targeting of certain proteins (Beller et al., 2008; Guo et 
al., 2008). In an alternative model GPAT4 is transported from the ER to LDs by 
vesicular trafficking. We found that in the absence of the COPI machinery, GPAT4, 
similar to ATGL, does not re-localize to LDs. Based on our in vitro studies, the COPI 
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machinery acts directly at the surface of the LD where it buds “nano-LDs” (~60-nm 
diameter) from a phospholipid covered TG-buffer surface. In mammalian cells as well 
as in Drosophila S2 cells we found βCOP, β’COP, or GBF1 foci in close proximity to 
LDs and colocalized with the LD marker protein perilipin3 suggesting a similar 
function in vivo. The direct action of COPI at the LD surface is further supported by 
previous work showing that (a) Arf1, as well as other members of the COPI 
machinery, were found on LDs in proteomic and cell biological studies (Bartz et al., 
2007b; Ellong et al., 2011; Nakamura et al., 2005); (b) expression of dominant-
negative Arf1 T31N localizes to LDs (Guo et al., 2008); and (c) Arf1Q71L that cannot 
hydrolyze GTP (and hence acts as a dominant negative in vesicular trafficking) 
activates lipolysis on LDs (Guo et al., 2008). The formation of “nano-LDs” by the 
COPI machinery leads to a decrease of phospholipids on the LD surface compared 
to the TG volume. This decrease in phospholipid levels suggests that the COPI 
machinery operates to remove excess phospholipids from the surface of LDs, 
thereby increasing LD surface tension and allowing for the recruitment of proteins. 
Modulating the lipid composition of the LD surface can, even in the absence of 
functional vesicular trafficking, restore the targeting of GPAT4. This proposes a 
function of COPI independent of its canonical function in retrograde vesicular 
trafficking. Electron microscopy revealed bridges between ER and LD, which 
suggested that GPAT4 re-localization to expanding LDs occurs through these 
connections. This re-localization of GPAT4 along membrane bridges is in agreement 
to the tubular GPAT4 signal found during FRAP experiments, where the signal on 
LDs recovered by re-localization of GPAT4 along tubular structures from the ER to 
LD. Most likely, these bridges are continuities of the outer ER membrane leaflet with 
the surface of the LD monolayer. Importantly, such structures between the ER and 
LDs have been observed before in other organisms, suggesting they are a principal 
feature of LDs (Ohsaki et al., 2008; Wanner et al., 1981). Interestingly these bridges 
between the ER and LDs are missing when βCOP is depleted (unpublished 
observation). During oleate loading of cells some LDs rapidly acquired GPAT4 after 
their initial formation. This suggests the establishment of a pathway for the re-
localization of these proteins and supports the idea that direct action of the COPI 
machinery leads to targeting of GPAT4. Mechanistically and consistent with our 
microfluidics experiments, LDs activated by COPI action could fuse with the ER 
establishing a continuous bridge between the ER and LD monolayer that allows 
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protein targeting, as it has been observed for GPAT4. This is in agreement with the 
rescue of GPAT4 targeting in a βCOP-depleted cell by the addition of stearylamine. 
Sterylamine decreases the surface tension and the line tension (Teixeira et al., 2000) 
making it easier for two membranes to fuse. Alternatively, protein targeting after 
action of the COPI machinery at LDs could be mediated by allowing proteins, such as 
ATGL, to bind exposed TG not covered by phospholipids. Intriguingly, the Arf1/COPI 
mechanism appears to operate particularly for proteins with a need to access the TG 
bulk phase of the LD, such as the TG lipase ATGL or the TG synthesis enzyme 
GPAT4. But also other membrane proteins, such as UBXD8 or METTL7B, initially 
localize to the ER and then concentrate on LDs in a similar fashion then GPAT4 
(Turro et al., 2006; Zehmer et al., 2009). This suggests an evolutionarily conserved 
pathway of ER-to-LD localization by membrane bridges, which is fundamental for 
targeting of these proteins to LDs. It will be interesting in the future to determine the 
set of proteins that are dependent on the COPI machinery on their targeting to LDs. 
Also the fate of the small LDs formed by the COPI machinery is unknown. One 
function of these “nano-LDs” in vivo could be to allow fast remodeling of LDs by 
Oswald ripening. Oswald ripening is the phenomena in which smaller particles in 
solution dissolve and deposit on larger particles in order to reach a more 
thermodynamically stable state wherein the surface to area ratio is minimized. In vitro 
studies have shown that generated “nano-LDs” are able to fuse with other LDs or 
bilayer membranes of giant unilamellar vesicles (GUVs). 
Once GPAT4 is localized to LDs, it does not leave this compartment in our 
experimental conditions. The mechanism mediating unidirectionality of LD targeting 
is unknown. One possibility is a unidirectional “gating” mechanism, perhaps 
mediated by a protein machinery. Another option is that GPAT4 has a higher 
preference for the monolayer than for the bilayer due to for example hydrophobic 
mismatching. Hydrophobic mismatching describes the difference between the length 
of the hydrophobic domain of an integral membrane protein and the hydrophobic 
thickness of the membrane (de Jesus and Allen, 2013). In the case of Drosophila 
GPAT4 the two transmembrane domains are unusually long for an ER-spanning α-
helix (21 and 22 aas), which leads to a structural strain as long as it is confined to a 
bilayer membrane of defined thickness. This strain is released once the protein 
localizes to the LD monolayer. The conformational change could result in a new 
folding state with a new and lower energy minimum, which could provide the energy 
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necessary for the enrichment of GPAT4 on LDs. This could also explain the trapping 
of GPAT4 on LDs since energy is needed to bring GPAT4 back into the bilayer 
conformation to allow re-localization to the ER bilayer. Supporting this hypothesis our 
data indicate that the hydrophobic domain of GPAT4 likely forms a hairpin loop rather 
than two separate transmembrane domains. Based on the sequence structure similar 
topologies are plausible for other enzymes of the de novo TG synthesis pathway. For 
example the topology of DGAT2 has been described to have similar features with the 
N- and the C-terminus facing the cytosol and a long hairpin loop for membrane 
targeting (Stone et al., 2006). Whether the loop domain between the two membrane 
domains is exposed to the luminal site is unknown. Further studies are needed to 
exactly map the topology of these proteins. Hydrophobic hairpins might be a common 
LD-targeting motif and highly similar topology has been described for oleosins, the 
major LD proteins of plants (Abell et al., 2002), or for caveolins (Thiele and Spandl, 
2008).  
Segregation of TG synthesis to LDs and away from the ER may have several 
important physiological functions. In a simple scenario cells could just form more LDs 
rather than expand existing LDs, which would only need one set of enzymes, namely 
the ER enzymes involved in the formation of LDs. This can be demonstrated by the 
LD morphology in adipocytes, which are the most specialized cells for lipid storage. 
In these cells only one giant LD is found with a size up to 100 µm in diameter that 
occupies 90% of the cell interior. Assuming a diameter of 100 µm, the volume of the 
LD is about 5.2x105 µm3.  If a cell would not be able to expand LDs but rather would 
form LDs with a diameter of 1 µm, it would need to form the incredible number of 106 
LDs in order to enclose the same amount of fat. This would mean that 100 times 
more surface phospholipids are needed to cover the fat. Also the space occupied by 
these amounts of LDs would be much higher and therefore the cell size would need 
to be enormous. Expansion of existing LDs allows the cell to save space and 
phospholipids for efficient storage of neutral lipids. Colocalizing enzymes of the TG 
synthesis pathway on LDs might facilitate the efficient handover of substrates from 
one enzyme to the next in a localized multi-enzyme complex. Consistent with this 
possibility, biochemical fractionations (e.g., of intestinal microsomes possibly 
containing LDs) demonstrated a complex containing several of the activities needed 
for TG synthesis (Lehner and Kuksis, 1995; Rao and Johnston, 1966), and recent 
data in C. elegans provide evidence for an interaction of DGAT2 and ACSL (Xu et al., 
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2012). In further support of this notion, we found ACSL1, ACSL3, GPAT4, and 
AGPAT3 physically associated when LDs are present and AGPAT3 and GPAT4 
colocalizing together to a subset of LDs. Moreover, depletion of a single LD-localized 
enzyme impaired localization of other enzymes and TG synthesis. All these data 
suggest the possibility of multi-enzyme complex formation, which might facilitate the 
efficient handover of substrates from one enzyme to the next and drive TG synthesis 
by making PA and DG unavailable for phospholipid synthesis. But segregation of TG 
synthesis to LDs may also serve to protect the ER from stress due to the 
accumulation of lipid synthesis intermediates, such as PA or DG. Accumulation of PA 
or DG could lead to an imbalance between phospholipid and neutral lipid synthesis. 
To achieve balance between phospholipid and neutral lipid synthesis, cells 
stringently regulate the availability of DG and PA for the different biosynthetic 
pathways. In yeast, a key enzyme for the regulation of this is the PA phosphatase 
Pah1, which regulates the availability of PA for phospholipid synthesis. The PCP-LD 
proteome revealed that the Drosophila homolog of Pah1 CG8709 localizes to LDs. 
Together with the segregation of GPAT and AGPAT activities to LDs, which would 
separate TG synthesis from ER-based phospholipid synthesis, this could provide a 
mechanism of how phospholipid and neutral lipid synthesis are coordinated.  
Expansion of the core of existing LDs is highly co-regulated with the expansion of the 
surface of these LDs. We found that CCT1, the rate-limiting enzyme in the Kennedy 
pathway, targets strongly to expanding LDs at early time points of LD formation. We 
further show that in general binding of CCT1 occurs on LDs with relatively low PC 
levels and that the binding leads to activation of CCT1. Activated rate-limiting CCT1 
increases the flux through the Kennedy pathway. This generates more PC to coat 
growing LDs and prevent their coalescence. It is unknown how PC enters expanding 
LDs since the final step of PC synthesis catalyzed by CPT occurs in the ER. A simple 
possibility is that PC is replaced when droplets connect to the ER and phospholipids 
can freely diffuse along the ER-LD connection sites. In another model proposed by 
Thiele et al., phospholipid fatty acids are remodeled by the Lands cycle (Penno et al., 
2013). Phospholipase A2 (PLA2) removes the sn-2 fatty acid of the phospholipid 
followed by re-acylation by lyso-phospholipid acyltransferases (LPLAT). Lyso-PC has 
a higher CMC in chloroform then PC and is therefore more water-soluble. This could 
allow relocation of lyso-PC to droplets, where LPLAT forms PC creating a sink-
source situation to drive PC formation on LDs. Interestingly, others and we have 
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found LPLAT on expanding LDs (Moessinger et al., 2011). Alternatively, PC can be 
targeted to LDs by transfer of PC from the ER to LDs via lipid transfer proteins. We 
found phosphatidylcholine transfer protein (PCTP) enriched in the LD fraction and 
confirmed the localization by fluorescence microscopy. Knockdown of PCTP does 
not mimic the CCT1 phenotype on LDs (Krahmer N., Wilfling F., and Walther TC. 
unpublished data). In Drosophila many lipid transfer proteins exist suggesting 
redundant function. But further experiments are necessary to determine the 
contribution of these proteins on LD PC homeostasis. 
Besides expanding LDs, a second class of LDs exists that does not contain GPAT4 
or any of the other TG synthesis enzymes. This class of LDs is much smaller in size 
and shows a uniform size distribution. Possibly, these LDs separate from the ER 
once they reach a particular size. The budding of these LDs from the ER prevents 
targeting of TG synthesis enzymes and their further growth and explains their 
relatively uniform size. Alternatively proteins might gate the connection between 
these droplets and the ER allowing only certain proteins to enter the LD surface. In 
plant cells, DGAT1 and DGAT2 have been described to localize to different 
subdomains within the ER (Shockey et al., 2006). Depletion of DGAT1, which leads 
to a strong decrease in formation of small LDs in our experiments, dramatically 
reduced the amount of stored TG. This decrease in overall TG suggests that LD-
localized TG synthesis enzymes need the initial formation of LDs by DGAT1 for 
efficient expansion. This hypothesis is further supported by the fact that initially 
formed LDs can acquire GPAT4 at much later time points after their formation. TG 
synthesis enzymes might exist in a low activity state when they are bound to the ER 
bilayer; re-localization and binding to the monolayer leads then to a switch from the 
low activity to the high activity state.  
The two different LD populations of static LDs (sLD) and expanding LDs (eLDs) are 
evolutionary conserved between flies and mice. Static LDs (sLD) are abundant, 
relatively small LDs of fairly uniform size, and their production is closely linked with 
TG synthesis in the ER. Expanding LDs (eLDs) are larger, more heterogeneous LDs 
that grow in the presence of excess fatty acids due to the relocalization of TG 
synthesis enzymes from the ER to the surfaces of specific LDs. Their relative 
contribution to TG storage is unknown, as are their functions in physiology. 
Mammalian genomes encode two enzymes with high similarity to Drosophila GPAT4, 
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GPAT3 and GPAT4, which constitute in most tissues about 90% of total GPAT 
activity (Coleman and Lee, 2004). So far, only GPAT4 function has been analyzed in 
knockout mice (Beigneux et al., 2006; Chen et al., 2008; Nagle et al., 2008; Vergnes 
et al., 2006). Absence of GPAT4 leads to subdermal lipodystrophy, as well as a 
strong reduction of TG content in adipose tissue and in liver, where GPAT4 is highly 
expressed. GPAT4 is further crucial for the production of milk fat by the mammary 
gland. The absence of GPAT4 leads to a resistance to diet-induced obesity, which 
suggests that it might be an interesting drug target (Cao et al., 2012). Besides 
GPAT4 some other mouse models have been studied for the absence of TG 
synthesis enzymes. The best-studied examples are DGAT1 and DGAT2. The 
absence of DGAT1 leads to reduced adiposity and resistance to diet-induced obesity 
(Smith et al., 2000). Further, dgat 1-/- mice have dry fur and hair loss (Smith et al., 
2000). In the absence of DGAT2, mice had a strong reduction in triglyceride 
synthesis and died at birth (Stone et al., 2004). It will be interesting to test the 
physiological role of the different types of droplets in an in vivo model, for example to 
determine the fate of the two different populations during lipolysis. The finding of the 
different LD populations shows that lipid droplets are more then just a depot of fat but 
in fact are dynamic organelles interacting with many cellular processes and might 
have a key role in certain pathways. 
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